LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm

TheSchall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstStride, Inc. (“Stride” or “the Company”) (NYSE: LRN) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities

International Geothermal Standard Committee Launched in Beijing with Permanent Secretariat at Sinopec

The International Geothermal Standard Committee (“IGSC”) was officially established on November 26 in Beijing, with its permanent Secretariat hosted by China Petroleum and Chemical Corporation (HKG: 0386, “Sinopec”), marking a historic milestone in global geothermal standardization. https://mma.prnewswire.com/media/2834964/International_Geothermal_Standard_Committee_Launched_Beijing_Permanent_Secretariat_Sinopec.jpg Initiated by the International Geothermal Association (IGA), the IGSC brings together 30 leading experts from 15 countries as

Alexandria Real Estate Equities, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – ARE

The DJS Law Group reminds investors of a class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria ” or “the Company”) (NYSE: ARE ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of

Heavy Rare Earth Global Crisis Spotlights Norra Karr in Sweden

(TSX-V:LEM),(OTC US:LEMIF),(Other OTC:LEMIF),(Nasdaq First North Sweden:LEMSE), VANCOUVER, British Columbia, Nov. 30, 2025 (GLOBE NEWSWIRE) — Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) provides a progress update on the Norra Karr Heavy Rare Earth Elements Project (“HREE”) being developed by the Company's wholly-owned

Heavy Rare Earth Global Crisis Spotlights Norra Karr in Sweden

Heavy Rare Earth Global Crisis Spotlights Norra Karr in Sweden GlobeNewswire December 01, 2025 VANCOUVER, British Columbia, Nov. 30, 2025 (GLOBE NEWSWIRE) — Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) provides a progress update on the Norra Karr Heavy Rare Earth Elements

The Wisdom Derived from the Great Migration: Hakka Medicine – The Unique “Medical Epic” of the Hakka People

From November 23rd to 25th, the 7th WorldHakka Conference was held in Meizhou, Guangdong. With the theme “Gathering Global Hakka Businesspeople to Foster High-Quality Development,” the conference adhered to the principles of “openness, innovation, cooperation, and win-win,” providing a platform to explore new opportunities in Hakka culture and industrial development. At this globally anticipated event,

NKKTech Global Accelerates APAC Expansion with Singapore Commercial Office and Strong Presence at Major Technology Events

NKKTech Global, an AI and software engineering company headquartered in Hanoi, Vietnam, has announced the acceleration of its APAC expansion strategy through the opening of its international commercial office in Singapore. The company continues to strengthen its presence at major technology events, including the Singapore FinTech Festival (SFF) 2025, where it showcased advanced AI, blockchain,

China Chunlai Announces 2025 Annual Results

28 November 2025, China Chunlai Education Group Co., Ltd. ('China Chunlai' or the 'Company', together with its subsidiaries and its consolidated affiliated entities, the 'Group', Stock Code: 1969) is pleased to announce the audited consolidated annual results of the Group for the year ended 31 August 2025 (the 'Reporting Period'). During the Reporting Period, the

Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that Eisai has filed a new drug application for "LEQEMBI(R)" (brand name, generic name: lecanemab) seeking approval for a subcutaneous formulation (subcutaneous autoinjector: SC-AI) as a new route of administration

Scroll to Top